Search results
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’
Fox News· 17 hours agoAn experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration...
FDA panel approves Alzheimer's drug that can slow disease
First Coast News· 2 days agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...
FDA panel approves Alzheimer's drug that can slow disease
WZZM 13 Grand Rapids· 2 days agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 1 day agoA Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that the...
FDA panel approves Alzheimer's drug that can slow disease
WUSA 9 Washington, D.C.· 2 days agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...
Unanimous FDA panel backs Lilly Alzheimer's drug
Axios· 2 days agoA unanimous panel of federal drug advisers on Monday concluded that Eli Lilly's experimental Alzheimer's drug donanemab benefits patients with early...
FDA panel endorses approval of Alzheimer’s drug shown to slow progression of disease
WSB Radio· 22 hours agoA panel of independent advisors to the U.S. Food and Drug Administration has recommended an...
US medical advisers vote to recommend Eli Lilly Alzheimer drug
Medical Xpress· 1 day agoAn independent panel of US medical experts voted Monday to recommend Eli Lilly's experimental Alzheimer's drug, meaning there could soon be another treatment option available ...
Advisory Panel of Experts Endorses FDA Approval of New Alzheimer’s Drug
The New York Times via Yahoo News· 1 day agoA committee of independent advisers to the Food and Drug Administration voted unanimously Monday...
FDA Panel Unanimously Recommends Eli Lilly’s Alzheimer’s Drug
Forbes· 2 days agoAll of the panel’s 11 members endorsed donanemab—which data from a clinical trial suggests can slow...